Annual report
4626.TEDINET S100O9US
Period2021-04-01 → 2022-03-31
Filed2022-06-20
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥98.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥81.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥70.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥59.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥52.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥18.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥13.9bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥18.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥13.8bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.9bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.2bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥17.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.4bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.4bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.9bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥12.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥9.6bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥189.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥179.0bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥142.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥105.7bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥111.5bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥103.8bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥102.5bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥85.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥76.5bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥69.5bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥70.5bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥73.0bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥51.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥54.7bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥51.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥54.3bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥41.8bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥18.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥13.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.1bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥45.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥24.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥19.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥31.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥12.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥11.3bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥209.13 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.49 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.01 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.42 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.37 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,522.11 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,348.42 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,217.11 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,238.62 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,261.75 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 45.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.4% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,137 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 2,067 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,988 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,614 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 1,268 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥11.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥7.8bn | 2020-04-01 → 2021-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥12.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥2.5bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥5.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.8bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.0bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥3.5bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥5.5bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥4.1bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥4.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.8bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥262m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥128.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥134.9bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥110.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥73.1bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥77.3bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥76.0bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥82.0bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥52.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥52.9bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥53.5bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥52.1bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥51.9bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥21.1bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥31.4bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥96.89 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.34 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.87 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.7 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.57 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥69.55 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80.1 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65.1 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65.1 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80.1 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥938.85 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥936.04 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥941.48 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥919.76 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥901.92 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 41.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.2% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.3% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.2% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.0% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.5% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 58,083,128 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,997,004 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,939,294 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,777,972 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,665,888 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 154 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 133 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 112 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 107 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 81 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 67
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥332m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥382m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 436 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥8.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥28m |
| Electronic Equipment Materialsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Electronic Equipment Materialsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Electronic Equipment Materialsreportable segment | employees | at 2022-03-31 | 1291 pure |
| Electronic Equipment Materialsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥71.1bn |
| Electronic Equipment Materialsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥71.1bn |
| Electronic Equipment Materialsreportable segment | segment assets | at 2022-03-31 | ¥78.2bn |
| Electronic Equipment Materialsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥17.1bn |
| Medical And Pharmaceuticalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6.3bn |
| Medical And Pharmaceuticalreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| Medical And Pharmaceuticalreportable segment | employees | at 2022-03-31 | 410 pure |
| Medical And Pharmaceuticalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥23.5bn |
| Medical And Pharmaceuticalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥23.5bn |
| Medical And Pharmaceuticalreportable segment | segment assets | at 2022-03-31 | ¥65.1bn |
| Medical And Pharmaceuticalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.4bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥9.5bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥6.5bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥94.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥94.6bn |
| —segment total | segment assets | at 2022-03-31 | ¥143.4bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥9.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥6.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥98.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥98.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥154m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥151.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-04-01 → 2021-03-31 | ¥417m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥380m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-04-01 → 2021-03-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥147m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-03-31 | ¥7.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥32m |
| Electronic Equipment Materialsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3.4bn |
| Electronic Equipment Materialsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥1.7bn |
| Electronic Equipment Materialsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥53.1bn |
| Electronic Equipment Materialsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥53.1bn |
| Electronic Equipment Materialsreportable segment | segment assets | at 2021-03-31 | ¥62.2bn |
| Electronic Equipment Materialsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥11.2bn |
| Medical And Pharmaceuticalreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥8.1bn |
| Medical And Pharmaceuticalreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥4.4bn |
| Medical And Pharmaceuticalreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥24.6bn |
| Medical And Pharmaceuticalreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥24.6bn |
| Medical And Pharmaceuticalreportable segment | segment assets | at 2021-03-31 | ¥62.1bn |
| Medical And Pharmaceuticalreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥11.5bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥6.1bn |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥77.7bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥77.7bn |
| —segment total | segment assets | at 2021-03-31 | ¥124.2bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥81.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥81.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥132.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥15.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,494
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | － | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | － | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | － | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | － | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.972 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.809 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.923 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.359 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.484 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.159 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.100 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.996 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.415 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.443 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00913-000ElectronicEquipmentMaterialsReportableSegmentsMember | 1291 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 410 | |
| Number of employees | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 436 | |
| Number of employees | CurrentYearInstant | 2137 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 154 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 39.6 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 9.4 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8312238 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration | 3611000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00913-000ElectronicEquipmentMaterialsReportableSegmentsMember | 3312000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 122000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00913-000ElectronicEquipmentMaterialsReportableSegmentsMember | 3222000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 6279000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 331000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_UnallocatedAmountsAndEliminationMember | 1678000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 11511000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 58083128 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 58083128 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 58083128 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 58083128 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 38 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 28 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 61 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 175 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 10 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 5273 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 5585 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 142281 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 3787 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 222959 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 98093 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 68 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |